Acemetacin - CAS 53164-05-9
Catalog number: 53164-05-9
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Cox-2 | COX
COX inhibitor; A non-steroidal anti-inflammatory drug
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
COX inhibitor; A non-steroidal anti-inflammatory drug
Pale Yellow to Light Yellow Solid
Please store the product under the recommended conditions in the Certificate of Analysis.
Quality Standard:
Melting Point:
Canonical SMILES:
1.Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D1, Isaac MG, McCleery J, Tabet N. Cochrane Database Syst Rev. 2012 Feb 15;2:CD006378. doi: 10.1002/14651858.CD006378.pub2.
BACKGROUND: Alzheimer's disease (AD) is the most common form of dementia. The incidence of AD rises exponentially with age and its prevalence will increase significantly worldwide in the next few decades. Inflammatory processes have been suspected in the pathogenesis of the disease.
2.Acemetacin cocrystals and salts: structure solution from powder X-ray data and form selection of the piperazine salt.
Sanphui P1, Bolla G1, Nangia A1, Chernyshev V2. IUCrJ. 2014 Feb 28;1(Pt 2):136-50. doi: 10.1107/S2052252514004229. eCollection 2014.
Acemetacin (ACM) is a non-steroidal anti-inflammatory drug (NSAID), which causes reduced gastric damage compared with indomethacin. However, acemetacin has a tendency to form a less soluble hydrate in the aqueous medium. We noted difficulties in the preparation of cocrystals and salts of acemetacin by mechanochemical methods, because this drug tends to form a hydrate during any kind of solution-based processing. With the objective to discover a solid form of acemetacin that is stable in the aqueous medium, binary adducts were prepared by the melt method to avoid hydration. The coformers/salt formers reported are pyridine carboxamides [nicotinamide (NAM), isonicotinamide (INA), and picolinamide (PAM)], caprolactam (CPR), p-aminobenzoic acid (PABA), and piperazine (PPZ). The structures of an ACM-INA cocrystal and a binary adduct ACM-PABA were solved using single-crystal X-ray diffraction. Other ACM cocrystals, ACM-PAM and ACM-CPR, and the piperazine salt ACM-PPZ were solved from high-resolution powder X-ray diffraction data.
3.Proniosomal oral tablets for controlled delivery and enhanced pharmacokinetic properties of acemetacin.
Shehata TM1, Abdallah MH, Ibrahim MM. AAPS PharmSciTech. 2015 Apr;16(2):375-83. doi: 10.1208/s12249-014-0233-5. Epub 2014 Oct 16.
Free-flowing proniosomal powders of acemetacin (AC) were prepared using the slurry method and maltodextrin as carrier. Positively charged proniosomes composed of 70:20:10 of Span 60/cholesterol (Chol)/stearylamine (SA), respectively, were successively compressed into tablets using direct compression method. The tablets were characterized for weight variability, friability, hardness, drug content uniformity, and dissolution properties. The in vivo evaluation of the prepared proniosomes (powder or tablet forms) after oral administration was investigated by the determination of AC and its active metabolite indomethacin (IND) in the blood of albino rabbits. Results indicated that the increase of Chol from 10% to 20% markedly reduced the efflux of the drug. Further Chol addition from 30% to 50% led to increased AC release rates. The proniosome tablets of AC showed greater hardness and disintegration time and less friability than AC plain tablets.
4.Bilateral sacroiliitis and uveitis comorbidity: brucellosis? Ankylosing spondylitis?
Akyol L1, Aslan K2, Özgen M1, Sayarlioglu M1. BMJ Case Rep. 2015 Sep 22;2015. pii: bcr2015211461. doi: 10.1136/bcr-2015-211461.
We present a rare case of a comorbidity of sacroiliitis and brucellosis infection. A 28-year-old woman received irregular medication due to ongoing backache and hip pain for 5 years. The patient presented to our hospital for evaluation of visual loss and was diagnosed with uveitis. Sacroiliac MRI was performed to investigate the inflammatory backache and hip pain, and the aetiology of the uveitis, revealing the presence of sacroiliitis. The patient's blood test results were as follows: positive brucellosis Rose Bengal test and positive tube agglutination test with a titre of 1/640. The patient was treated with doxycycline and rifampicin for 8 weeks for the brucellosis infection, and with acemetacin for the ankylosing spondylitis. The patient's back and hip pain decreased significantly 8 weeks later; however, the uveitis was not controlled by the treatment. Therefore, anti-tumour necrosis factor (infliximab) treatment was started.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Cox-2 Products

CAS 53164-05-9 Acemetacin

(CAS: 53164-05-9)

COX inhibitor; A non-steroidal anti-inflammatory drug

CAS 70374-39-9 Lornoxicam

(CAS: 70374-39-9)

A non-steroidal COX-1/COX-2 inhibitor; A nonsteroidal anti-inflammatory drug

CAS 69-72-7 Salicylic acid

Salicylic acid
(CAS: 69-72-7)

Salicylic acid is a natural product extract from Willow bark, well known as an antiinflammatory inhibitor of cyclooxygenase activity. It is widely used in organ...

CAS 170569-88-7 Mavacoxib

(CAS: 170569-88-7)

Mavacoxib, a pyrazol derivative, has been found to be a COX-2 Inhibitor that could be used in pain and inflammation therapy for dogs.

CAS 74103-07-4 Ketorolac

(CAS: 74103-07-4)

A non-selective COX inhibitor of COX-1 and COX-2 with IC50 of 1.23 μM and 3.50 μM, respectively

CAS 169590-41-4 Deracoxib

(CAS: 169590-41-4)

Deracoxib is a non-steroidal anti-inflammatory drug (NSAID) of the coxib class. Deracoxin is a selective cyclooxygenase-2 (COX-2) inhibitor used in the treatmen...

CAS 169590-42-5 Celecoxib

(CAS: 169590-42-5)

A highly selective COX-2 inhibitor

CAS 78281-72-8 Nepafenac

(CAS: 78281-72-8)

An inhibitor of COX-1 and COX-2

CAS 156897-06-2 Licofelone

(CAS: 156897-06-2)

A dual inhibitor of COX-1/COX-2 and 5-LO

CAS 787623-48-7 COX-2-IN-1

(CAS: 787623-48-7)

A potent and slective COX-2 inhibitor(IC50= 3.9 μM)

CAS 220991-20-8 Lumiracoxib

(CAS: 220991-20-8)

A novel, selective COX-2 inhibitor; Phase 4

CAS 51803-78-2 Nimesulide

(CAS: 51803-78-2)

A selective COX-2 inhibitor

CAS 53716-49-7 Carprofen

(CAS: 53716-49-7)

A COX-2 inhibitor; A non-steroidal anti-inflammatory drug

CAS 443919-96-8 CAY10416

(CAS: 443919-96-8)

A dual COX-2/5-LO inhibitor

CAS 123653-11-2 NS 398

NS 398
(CAS: 123653-11-2)

A selective COX-2 inhibitor

CAS 99464-64-9 Ampiroxicam

(CAS: 99464-64-9)

Ampiroxicam is a nonselective cyclooxygenase inhibitor uesd as anti-inflammatory drug.

CAS 168433-84-9 SC58451

(CAS: 168433-84-9)

SC58451 is a potent and selective Cox-2 (IC50= 1.1 nM) and was found to be orally active (EDs0 = 0.3 mpk) in the rat<br/>adjuvant-induced arthritis model with n...

CAS 26159-34-2 Naproxen Sodium

Naproxen Sodium
(CAS: 26159-34-2)

A COX inhibitor for COX-1 and COX-2 with IC50 of 8.7 μM and 5.2 μM, respectively.

CAS 88149-94-4 DuP-697

(CAS: 88149-94-4)

A selective COX-2 inhibitor

CAS 198470-85-8 Parecoxib Sodium

Parecoxib Sodium
(CAS: 198470-85-8)

The prodrug Parecoxib as well as its active metabolite val have a specific affinity to the cannabinoid (CB) receptor measured in CB1-expressing HEK 293 cells an...

Chemical Structure

CAS 53164-05-9 Acemetacin

Quick Inquiry

Verification code

Featured Items